Outcome | Effect size random effects model –SMD* (95%CI) | Statistical heterogeneity (I2) |
---|---|---|
Primary outcome (CRF) | ||
Supervised aerobic exercise | −0.51, 95%CI [−0.81, −021], (P = 0.001) † | 75% |
Supervised resistance training | −0.41, 95%CI [−0.76, −0.05], (P = 0.02) † | 64% |
Supervised exercise during active anti-cancer treatment | −0.66, 95%CI [−1.08, −0.23], (P = 0.002) † | 78.6% |
Supervised exercise after anti-cancer treatment | −0.25, 95%CI [−0.55, 0.05], (P = 0.10) | 85.8% |
Secondary outcomes | ||
Depression | −0.23, 95%CI [−0.55, 0.09], (P = 0.16) | 69% |
Body mass index | −0.14, 95%CI [−0.38, 0.11], (P = 0.28) | 0% |
Physical activity level | 1.10, 95%CI [−0.41, 2.62], (P = 0.15) | 85% |
Health-related quality of life | ||
Physical wellbeing | 0.63, 95%CI [0.08, 1.18], (P = 0.02) † | 89% |
Functional wellbeing | 0.60, 95%CI [0.08, 1.11], (P = 0.02) † | 89% |
Social wellbeing | 0.08, 95%CI [−0.11, 0.27], (P = 0.24) | 28% |
Emotional wellbeing | 0.30, 95%CI [−0.05, 0.65], (P = 0.09) | 76% |